Inicio › Leucemia mielógena aguda › Míchigan › Ann Arbor
Ensayos clínicos de Leucemia mielógena aguda en Ann Arbor, MI
17 estudios para Leucemia mielógena aguda buscan participantes en centros de Ann Arbor y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · A 15 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · A 18 mi de distancia
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ReclutandoFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · A 15 mi de distancia
- y 1 más
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
ReclutandoFase 1
- C S Mott Children's Hospital, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- y 4 más
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · A 15 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · A 18 mi de distancia
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ReclutandoFase 3
- Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · A 15 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · A 18 mi de distancia
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · A 15 mi de distancia
- y 1 más
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · A 7 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · A 15 mi de distancia
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · A 18 mi de distancia
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ReclutandoFase 3
- C S Mott Children's Hospital, Ann Arbor
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
ReclutandoFase 3
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ReclutandoFase 1/2
- C S Mott Children's Hospital, Ann Arbor
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
ReclutandoFase 3
- C.S. Mott Children's Hospital, Ann Arbor
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ReclutandoFase 3
- University of Michigan, Ann Arbor
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- University of Michigan, Ann Arbor
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
ReclutandoFase 1
- University of Michigan, Ann Arbor
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ReclutandoFase 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Más información sobre Leucemia mielógena aguda en MedlinePlus
Ensayos de Leucemia mielógena aguda en otras ciudades
- Houston, TX85 estudios
- New York City, NY51 estudios
- Boston, MA44 estudios
- Seattle, WA41 estudios
- Baldwin Park, CA40 estudios
- Columbus, OH35 estudios
- Philadelphia, PA34 estudios
- Durham, NC33 estudios
- Atlanta, GA31 estudios
- Tampa, FL29 estudios
- Chicago, IL26 estudios
- Portland, OR25 estudios
Otros estudios en Ann Arbor
- Cáncer de seno27 estudios
- Cáncer de próstata27 estudios
- Cáncer de pulmón de células no pequeñas26 estudios
- Cáncer (todos los tipos)25 estudios
- Cáncer de pulmón23 estudios
- Cáncer del colon y del recto23 estudios
- Fallo cardíaco22 estudios
- Enfermedad cardiovascular16 estudios
- Cáncer de páncreas14 estudios
- Melanoma12 estudios
- Accidente cerebrovascular12 estudios
- Carcinoma de células escamosas de cabeza y cuello12 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.